Evidence map›Paper›PMID 37654571›Full record

ReviewFrontiers in endocrinology2023

Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines.

Nazanin Aghamohamadi, Faezeh Shahba, Ali Zarezadeh Mehrabadi, Hossein Khorramdelazad, Milad Karimi, Reza Falak, Reza Zolfaghari Emameh

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nazanin AghamohamadiDepartment of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Faezeh ShahbaDepartment of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Ali Zarezadeh MehrabadiDepartment of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Hossein KhorramdelazadDepartment of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Milad KarimiDepartment of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Reza FalakDepartment of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Reza Zolfaghari EmamehDepartment of Energy and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is potentially pathogenic and causes severe symptoms; in addition to respiratory syndromes, patients might experience other severe conditions such as digestive complications and liver complications injury. The abnormality in the liver is manifested by hepatobiliary dysfunction and enzymatic elevation, which is associated with morbidity and mortality. The direct cytopathic effect, immune dysfunction, cytokine storm, and adverse effects of therapeutic regimens have a crucial role in the severity of liver injury. According to aging and immune system alterations, cytokine patterns may also change in the elderly. Moreover, hyperproduction of cytokines in the inflammatory response to SARS-CoV-2 can lead to multi-organ dysfunction. The mortality rate in elderly patients, particularly those with other comorbidities, is also higher than in adults. Although the pathogenic effect of SARS-CoV-2 on the liver has been widely studied, the impact of age and immune-mediated responses at different ages remain unclear. This review discusses the association between immune system responses in coronavirus disease 2019 (COVID-19) patients of different ages and liver injury, focusing on cytokine alterations.

Indexed as

COVID-19AdultAgedAgingCytokinesHumansLiverSARS-CoV-2CytokinesagingCOVID-19cytokine storminterleukinliver injurySARS-CoV-2

Identifiers

PMID37654571
PMCPMC10465349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.